Hepatitis B surface antigen (HBsAg) prevalence in Guinea-Bissau
Guinea-Bissau: Hepatitis B surface antigen (HBsAg) prevalence was 2.7% in 2024. ▼ Falling
Latest (2024)
2.7%
Change on year
up 3.8%
World rank
8th
of 194 countries
All-time high
2.9%
in 2015
All-time low
2.6%
in 2022
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Guinea-Bissau, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hepatitis b surface antigen (hbsag) prevalence in Guinea-Bissau stood at 2.7%.
The figure is up 3.8% on the previous year and down 6.9% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Guinea-Bissau peaked at 2.9% in 2015 and was at its lowest, 2.6%, in 2022.
Guinea-Bissau ranks 8th of 194 countries on this measure, in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Guinea-Bissau, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.9% | — |
| 2016 | 2.8% | -3.4% |
| 2017 | 2.7% | -3.6% |
| 2018 | 2.7% | +0.0% |
| 2019 | 2.9% | +7.4% |
| 2020 | 2.8% | -3.4% |
| 2021 | 2.9% | +3.6% |
| 2022 | 2.6% | -10.3% |
| 2023 | 2.6% | +0.0% |
| 2024 | 2.7% | +3.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.8% | 2.7% | 2.9% | 5 |
| 2020s | 2.7% | 2.6% | 2.9% | 5 |
Countries ranked near Guinea-Bissau
More health data for Guinea-Bissau
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7721 % change on previous year (2090)
- Heat deaths vs projected death rates 1,070 (2090)
- Un projection of annual infant deaths 941 (2100)
- Population ages 0-14, female, annual growth rate 0.9575 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1892 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.9903 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1941 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Guinea-Bissau?
- Hepatitis b surface antigen (hbsag) prevalence in Guinea-Bissau was 2.7% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Guinea-Bissau?
- The highest recorded value was 2.9% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Guinea-Bissau?
- The lowest recorded value was 2.6% in 2022.
- How does Guinea-Bissau rank for hepatitis b surface antigen (hbsag) prevalence?
- Guinea-Bissau ranks 8th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Guinea-Bissau?
- Over the last ten years it is down 6.9%. The long-run trend across the full record is falling.
- Where does this Guinea-Bissau data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).